T/NBPIA 006.2-2021 Active Group standards

T/NBPIA 006.2-2021 Prevention Guidelines for Cross-Infection in Hemodialysis Room - Part 2: Mucosal Transmission Diseases

Publish Date: 2021-03-10 Implement Date: 2021-06-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/NBPIA 006.2-2021

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: Medical devices

ICS Name: Other standards related to disinfection and sterilization

Publish Date: 2021-03-10

Implement Date: 2021-06-01

Scope

Main technical content: Hospitals are one of the main pathways for the outbreak and spread of acute respiratory infectious diseases through nosocomial infections. Therefore, managing close contacts of related respiratory infectious diseases and suspected or confirmed patients is crucial to preventing the further transmission of new cases among families and public places. Medical observation or isolation treatment of the general population is relatively easy to implement. Since daily necessities such as food and clothing can be delivered to the isolation areas, there are no mandatory reasons to leave the isolation areas. They can stay in the isolation rooms to receive observation and treatment until the end of the isolation period. If no symptoms occur during the isolation period, they can be discharged from isolation directly after the isolation period ends. For patients undergoing blood purification, due to their weakened physical condition, multiple complications and comorbidities, low immunity, and the need to share common areas during hemodialysis in densely populated environments, respiratory transmissible diseases are highly likely to outbreak in blood purification rooms. Compared with the general population, the challenges of medical observation or isolation treatment for blood purification patients are much more complex: (1) Blood purification patients have weak immunity and are vulnerable to microbial attacks, including viruses. (2) Blood purification patients often suffer from various chronic complications and comorbidities, and the risk of non-epidemic-related medical events during medical observation and isolation treatment is high. (3) Blood purification patients need to leave the isolation areas 2-4 times per week to receive hemodialysis treatment by some means of transportation. They are often physically weak and have a high prevalence of muscle atrophy. During the transfer of patients from the isolation areas to the hemodialysis rooms, there is a hig